Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years’ Experience from the PATRO Children Study-Reference-Cited by-同舟云学术

Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years’ Experience from the PATRO Children Study

Published:2020 Issue:3 Volume:93 Page:154-163
ISSN:1663-2818
Container-title:Hormone Research in Paediatrics
language:en
Short-container-title:Horm Res Paediatr

Author:

Pfäffle Roland,Bidlingmaier Martin,Kreitschmann-Andermahr Ilonka,Land Christof,Partsch Carl Joachim,Schwab Karl Otfried,Sommer Heide,Backeljauw Philippe,Kanumakala Shankar,Loche Sandro,Zouater Hichem,Strasburger Christian J.

Publisher

S. Karger AG

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Reference15 articles.

1. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab. 1958 Aug;18(8):901–3.

2. Ranke MB, Wit JM. Growth hormone - past, present and future. Nat Rev Endocrinol. 2018 May;14(5):285–300.

3. Pfäffle R, Schwab KO, Marginean O, Walczak M, Szalecki M, Schuck E, et al. Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® in children requiring growth hormone treatment. Ther Adv Endocrinol Metab. 2013 Feb;4(1):3–11.

4. Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010 Jan;95(1):167–77.

5. Bonfig W, Lindberg A, Carlsson M, Cutfield W, Dunger D, Camacho-Hübner C, et al. Efficacy of growth hormone treatment in children with type 1 diabetes mellitus and growth hormone deficiency-an analysis of KIGS data. J Pediatr. 2018 Jul;198:260–4.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guidelines for the care of girls and women with Turner syndrome;European Journal of Endocrinology;2024-05-15

2. Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?;Biomedicines;2024-05-08

3. Potential for Optimization of Growth Hormone Treatment in Children with Growth Hormone Deficiency, Small for Gestational Age, and Turner Syndrome in Germany: Data from the PATRO<sup>®</sup> Children Study;Hormone Research in Paediatrics;2024-04-25

4. Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis;Scientific Reports;2024-04-05

5. Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study;Drug Design, Development and Therapy;2024-03